MedTrace Logo

DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients

NCT06357195 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-08-11

No results posted yet for this study

Summary

The goal of this observational study is to learn about current practices for the acute neuropsychiatric management of older adults during emergency department (ED) visits. Researchers will compare current standard of care practices with implemented guideline practice to see if standardized medication guidelines help reduce the usage of antipsychotics and/or benzodiazepines during acute presentations. The main questions this study aims to answer are:

* How many older adults are receiving antipsychotics or benzodiazepines during emergency department visits?
* Why are older adults receiving antipsychotics or benzodiazepines during emergency department visits?
* How many older adults who receive antipsychotics or benzodiazepines during emergency department visits have an underlying cognitive or movement disorder?
* What effects does administration of antipsychotics or benzodiazepines during emergency department visits have on patient outcomes in older adults and adults with neurocognitive disorders?
* Does implementation of standardized medication guidelines help reduce the usage of antipsychotics and/or benzodiazepines during acute presentations?

Conditions

  • Emergency Psychiatric
  • Cognition Disorder
  • Movement Disorders
  • Antipsychotics and Neuroleptics Toxicity
  • Dementia With Lewy Bodies
  • Alteration in Mental Status
  • Behavior
  • Aging

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Eligibility

Min Age
54 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2026-01-01
Completion
2026-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06357195 on ClinicalTrials.gov